A Preview Of Sarepta Therapeutics's Earnings
Portfolio Pulse from Benzinga Insights
Sarepta Therapeutics (NASDAQ:SRPT) is scheduled to release its quarterly earnings report on February 28, 2024, with an estimated EPS of $0.01. Historical data shows the company has previously beaten EPS estimates, leading to positive stock price movements. Shares are currently trading at $137.65, down 3.01% over the last year. Investors are looking for a beat on the EPS estimate and positive future guidance.
February 27, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sarepta Therapeutics is expected to report an EPS of $0.01 for the latest quarter, with historical performance showing positive stock movements post-earnings beats. The stock is currently down 3.01% over the last year.
Given Sarepta Therapeutics' history of beating EPS estimates and the subsequent positive impact on its stock price, a similar outcome could be expected if the company beats the EPS estimate again and provides positive future guidance. However, the current year-to-date negative return of 3.01% indicates that investors may have concerns, making the upcoming earnings report particularly significant.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100